FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/094757 [Registered on: 15/09/2025] Trial Registered Prospectively
Last Modified On: 13/09/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   To Evaluate The Efficacy Of Ropana Effect Of Priyangvadi Churna On Shuddha Vrana. 
Scientific Title of Study   A Randomised Controlled Clinical Trial To Evaluate The Ropana Effect By Avachurnan Of Priyangvadi Churna On Shuddha Vrana 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Gaikwad Ruturaj Mohanrao 
Designation  PhD Scholar 
Affiliation  Yeshwant Ayurvedic College 
Address  Yeshwant Ayurvedic College Ap kodoli Tal panhala Dist kolhapur

Kolhapur
MAHARASHTRA
416114
India 
Phone  9960760638  
Fax    
Email  ruturajmgaikwad@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr LAXMI MAROTI NARHARE 
Designation  Professor of Shalyatantra Department  
Affiliation  Yeshwant Ayurvedic College 
Address  Yeshwant Ayurvedic College, Ap Kodoli,Tal-Panhala, Kolhapur

Kolhapur
MAHARASHTRA
416114
India 
Phone  9822189226  
Fax    
Email  drlaxminarhare@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr LAXMI MAROTI NARHARE 
Designation  Professor of Shalyatantra Department  
Affiliation  Yeshwant Ayurvedic College 
Address  Yeshwant Ayurvedic College, Ap Kodoli,Tal-Panhala, Kolhapur

Kolhapur
MAHARASHTRA
416114
India 
Phone  9822189226  
Fax    
Email  drlaxminarhare@gmail.com  
 
Source of Monetary or Material Support  
Yeshwant Ayurved Medical college Shalyatantra Department, Kodoli, District. Kolhapur 
 
Primary Sponsor  
Name  Dr Ruturaj Mohanrao Gaikwad 
Address  Yeshwant Ayurvedic College, Ap. Kodoli,Tal-Panhala, Kolhapur 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ruturaj Mohanrao Gaikwad  Yeshwant Ayurvedic Dharmarth Rugnalaya  Yeshwant Ayurvedic dharmarth Rugnalaya shalyatantra male and female ward no 1 ,2 and shalyatantra opd ,Ap. Kodoli,Tal-Panhala, Kolhapur.
Kolhapur
MAHARASHTRA 
9960760638

ruturajmgaikwad@gmail.com 
 
Details of Ethics Committee  
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L989||Disorder of the skin and subcutaneous tissue, unspecified. Ayurveda Condition: SUDDHAVRANAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-avacUrNanam, अवचूर्णनम् (Procedure Reference: Bhavprakash vrana ropana chikitsa adhyay, Procedure details: 1.Vrana Prakshalan(cleaning of wound) will be done with normal saline. 2.Then sufficient amount of Priyangvadi Churna will dust over the wound 3..After that a sterile dressing pad having sufficient length will be placed over the wound. 4.Proper dressing will be done with sterile bandage cloth. 5.This will be repeated daily for 15 days)
(1) Medicine Name: Priyangvadi churna, Reference: Bhavprakash, Route: Topical, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: od, Duration: 15 Days
2Comparator Arm (Non Ayurveda)-Nanocrytalline silver gel
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  55.00 Year(s)
Gender  Both 
Details  Patients irrespective of gender, economic class, caste, religion
Patient having sign and symptoms of Shuddha Vrana having area less then length 5x 5 cm & max
depth 5 mm will be randomly selected 
 
ExclusionCriteria 
Details  Known cases of HIV, Hepatitis B, any systemic disease
Dushta Vrana(Infected wounds)
Diabetic ulcers
Tubercular Ulcers
Venous Ulcers
Leprotic Ulcers
Malignant Ulcers
Burns
Wounds having excessive loss of Tissues i.e.wound include bone,and tendon injury, exposed bone 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Alternation 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Relief from symptoms and wound healing  15 days 
 
Secondary Outcome  
Outcome  TimePoints 
Secondary outcome will be to determine whether the interventional
drug is better than the controller drug 
15 days 
 
Target Sample Size   Total Sample Size="120"
Sample Size from India="120" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   18/10/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

The thesis titled “A Randomized Controlled Clinical Study to Evaluate the Ropana Effect of Priyangvadi Churna Avachurnan on Shuddha Vrana” explores the role of a traditional Ayurvedic formulation in wound healing. In Ayurveda, Vrana (wound) is considered a critical condition that requires careful management, with Ropana (healing) being one of the sixty wound-care measures described by Acharya Sushruta. While modern medicine often employs antimicrobial dressings such as silver-based preparations, Ayurvedic classics highlight natural formulations like Priyangvadi Churna for their healing and restorative properties.


This study has been designed as a randomized controlled clinical trial with a total of 120 patients diagnosed with Shuddha Vrana (clean, non-infected wounds). The participants will be divided into two equal groups: the trial group will receive Priyangvadi Churna dressing through the Avachurnan method, while the control group will be treated with nanocrystalline silver gel, a widely accepted modern wound-healing agent. Both groups will undergo daily dressing for 15 days.


Assessment parameters include wound size reduction, discharge, color changes, tenderness, and granulation tissue development. Observations will be documented every three days. The collected data will be statistically analyzed to determine the comparative effectiveness of Priyangvadi Churna.


The study aims not only to validate the traditional claims of Ayurvedic texts but also to establish scientific evidence for using Priyangvadi Churna as a cost-effective, natural, and safe alternative in wound management. If successful, this research could strengthen integrative approaches in surgery and wound care, bridging classical Ayurvedic wisdom with modern clinical practice.


 
Close